In continuation to disclosure dated March 31, 2026, minor modification have been made in attached disclosure.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Hemant Surgical Industries has submitted a revised disclosure (originally filed on March 31, 2026) regarding its Semi Knocked Down (SKD) manufacturing agreement with US-based Sonomed Escalon. Under the deal, the company will manufacture two ophthalmic ultrasound device models — A-scan and pachymetry — in India for exclusive sale in the Indian market. Sonomed Escalon will supply the devices in SKD form at a preferential 'Transfer Price,' and Hemant Surgical will handle further localisation and distribution. The revised filing clarifies that there is no shareholding exchange, no special rights (such as board seats), and the deal is not a related-party transaction, though the promoter was previously an authorised distributor of Sonomed Escalon. No new material terms have been introduced; the changes are minor and aimed at improving clarity for investors.
This is a refinement of an already-disclosed partnership and not a new event, so limited immediate price impact is expected. However, it reinforces the company's push into the ophthalmic medical devices space through a tie-up with an established US player, potentially supporting future revenue growth in the Indian market.